Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs

[1]  B. Malinowska,et al.  Function of nociceptin and opioid OP4 receptors in the regulation of the cardiovascular system. , 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2]  S. Salvadori,et al.  [Nphe1,Arg14,Lys15]Nociceptin‐NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor , 2002, British journal of pharmacology.

[3]  D. Kapusta,et al.  Nociceptin/Orphanin Fq Modulates The Cardiovascular, But Not Renal, Responses To Stress In Spontaneously Hypertensive Rats , 2002, Clinical and experimental pharmacology & physiology.

[4]  Takao Ito,et al.  Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801 , 2002, British journal of pharmacology.

[5]  L. Chen,et al.  [Nphe1]nociceptin(1-13)-NH2 antagonizes nociceptin-induced hypotension, bradycardia, and hindquarters vasodilation in the anesthetized rat. , 2002, Canadian journal of physiology and pharmacology.

[6]  A. Hryniewicz,et al.  Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[7]  H. Mori,et al.  Effects of nociceptin on cardiac norepinephrine and acetylcholine release evoked by ouabain , 2001, Brain Research.

[8]  T. Kudo,et al.  Effects of nociceptinNH2 and [Nphe1]nociceptin(1–13)NH2 on rat brain noradrenaline release in vivo and in vitro , 2001, Neuroscience Letters.

[9]  M. Takahashi,et al.  Retro-nociceptin methylester, a peptide with analgesic and memory-enhancing activity. , 2000, Life sciences.

[10]  A. McKnight,et al.  Characterization of the ORL1 receptor on adrenergic nerves in the rat anococcygeus muscle , 2000 .

[11]  M. Salis,et al.  Studies of the cardiovascular effects of nociceptin and related peptides , 2000, Peptides.

[12]  J. Mogil,et al.  Effects of supraspinal orphanin FQ/nociceptin , 2000, Peptides.

[13]  D. Kapusta.  Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function , 2000, Peptides.

[14]  S. Salvadori,et al.  Nociceptin/orphanin FQ receptor ligands , 2000, Peptides.

[15]  K. Starke,et al.  Modulation of 3H‐noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β‐adrenoceptors in mouse tissues , 2000, British journal of pharmacology.

[16]  S. Salvadori,et al.  Pharmacology of nociceptin and its receptor: a novel therapeutic target , 2000, British journal of pharmacology.

[17]  S. Salvadori,et al.  Characterization of [Nphe1]nociceptin(1‐13)NH2, a new selective nociceptin receptor antagonist , 2000, British journal of pharmacology.

[18]  Su-Ying Wu,et al.  Nociceptin inhibits rat sympathetic preganglionic neurons in situ and in vitro. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  A. McKnight,et al.  Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle. , 2000, British journal of pharmacology.

[20]  H. Kannan,et al.  Nociceptin modulates renal sympathetic nerve activity through a central action in conscious rats. , 1999, The American journal of physiology.

[21]  D. Kapusta,et al.  Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  P. Li,et al.  Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla , 1999, Brain Research.

[23]  M. Salis,et al.  Cardiovascular effects of nociceptin in unanesthetized mice. , 1999, Hypertension.

[24]  B. Malinowska,et al.  Nociceptin inhibits the neurogenic vasopressor response in the pithed rat via prejunctional ORL1 receptors , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[25]  B. Bucher.  ORL1 receptor-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[26]  H. Champion,et al.  Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat , 1998, Regulatory Peptides.

[27]  A. Kastin,et al.  Endomorphin 1 and 2, Endogenous Ligands for the μ-opioid Receptor, Decrease Cardiac Output, and Total Peripheral Resistance in the Rat , 1997, Peptides.

[28]  H. Champion,et al.  Nociceptin, an Endogenous Ligand for the ORL1 Receptor, Decreases Cardiac Output and Total Peripheral Resistance in the Rat , 1997, Peptides.

[29]  J. Meunier,et al.  Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. , 1997, European journal of pharmacology.

[30]  S. L. Dun,et al.  Nociceptin-like immunoreactivity in autonomic nuclei of the rat spinal cord , 1997, Neuroscience Letters.

[31]  C. Maggi,et al.  Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. , 1997, European journal of pharmacology.

[32]  C. Maggi,et al.  Prejunctional modulation by nociceptin of nerve-mediated inotropic responses in guinea-pig left atrium. , 1997, European journal of pharmacology.

[33]  S. Salvadori,et al.  Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. , 1997, Journal of medicinal chemistry.

[34]  D. Grandy,et al.  Bidirectional modulatory effect of orphanin FQ on morphine‐induced analgesia: antagonism in brain and potentiation in spinal cord of the rat , 1997, British journal of pharmacology.

[35]  M. Belvisi,et al.  Naloxone‐insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea‐pig trachea by the novel opioid, nociceptin , 1997, British journal of pharmacology.

[36]  C. Maggi,et al.  Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide , 1996, British journal of pharmacology.

[37]  D. Grandy,et al.  Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor , 1995, Science.

[38]  Marc Parmentier,et al.  Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor , 1995, Nature.

[39]  R. Martin,et al.  Rapid estimation of catecholamines, octopamine and 5-hydroxytryptamine in biological tissues using high-performance liquid chromatography with coulometric detection. , 1983, Journal of chromatography.